Antibody engineering and production are essential tools in drug discovery, providing powerful and specific therapeutics and diagnostic/prognostic materials for various diseases. Antibodies are ...

Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...

CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies.  | The deal allows CSL to ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

The hybridoma methodology for developing monoclonal antibodies has been a lab staple for more than 30 years, and it still works great for immunohistochemistry and various cell biology techniques.

Thank you to everyone who attended our webinar ‘Antibodies to watch in 2026‘ in association with the journal, mAbs. Below are ...

Antibodies are among the most important protein-detecting reagents in research, yet they can be surprisingly unreliable. It’s an issue close to Alejandra Solache’s heart. “The way many antibodies are ...

ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, a global leader in antibodies, immunoassay kits, and recombinant proteins, today announced the launch of Multi-rAb Recombinant Secondary Antibodies, the ...

Transthyretin amyloid (ATTR) cardiomyopathy is an underdiagnosed and potentially fatal disease. It is characterized by the accumulation of transthyretin that becomes misshapen and builds up in the ...

The engineering and production of antibodies are vital in drug discovery, offering effective and precise therapeutics and diagnostic/prognostic materials for numerous diseases. Antibodies are proteins ...

The history of antibody engineering and production in drug discovery can be traced back to the 1970s and 1980s [1] when scientists first began to explore the potential of using antibodies as ...